CClinicalTrials.gg
CompletedNCT02219919Updated May 12, 2016

Nociceptive Gain Processing After Physical Therapy in Carpal Tunnel Syndrome

An interventional study of Surgical Group and Physical Therapy Group in Carpal Tunnel Syndrome, sponsored by Universidad Rey Juan Carlos. Completed at 2 sites in Spain. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-05-12.

Sponsored by Universidad Rey Juan Carlos · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

This randomized clinical trial will investigate changes in pain intensity and nociceptive gain processing after the application of either physical therapy or surgery in women with carpal tunnel syndrome (CTS). The purpose of this study will be to determine changes in pain intensity, widespread pressure pain sensitivity and segmental thermal changes after the application of a physical therapy program based on desensitization maneuvers of the central nervous system or endoscopic surgery in women with CTS at medium and long-term follow-up periods. We hypothesize that the physical therapy intervention targeted to desensitization of the central nervous system is more effective than surgical intervention for modulating altered nociceptive gain processing in women with CTS.

Read the detailed description

There is increasing evidence suggesting that carpal tunnel syndrome (CTS) represents a complex pain syndrome including both peripheral and central sensitization mechanisms. In fact, patients with unilateral CTS exhibit bilateral widespread pressure hyperalgesia and bilateral pain hypersensitivity suggesting the presence of altered nociceptive gain processing. In addition, these sensitization processes seem to be independent of electro-diagnostic findings. Previous studies support the use of physical therapy and surgical interventions for the management of pain and disability in these patients. However, there is no evidence related to changes in nociceptive gain process after the application of any therapeutic intervention. Preliminary evidence suggests that manual therapies can modulate sensitization mechanisms. Therefore, our objective is to conduct a randomized clinical trial to determine if manual therapies including desensitization maneuvers of the central nervous system are effective to decrease widespread pressure pain and thermal pain hypersensitivity in women with CTS.

02

Conditions studied

  • Carpal Tunnel Syndrome

Keywords

  • Carpal Tunnel Syndrome
  • Pain
  • Sensitivity
  • Pain Thresholds
  • Sensitization
  • Physical Therapy
03

In context

Carpal Tunnel Syndrome

589 studies on the registry are indexed under Carpal Tunnel Syndrome; 139 are open to participants now.

This study's enrollment of 100 is above the median of 60 across 445 interventional studies indexed under Carpal Tunnel Syndrome.

Browse Carpal Tunnel Syndrome studies →

Lead sponsor

Universidad Rey Juan Carlos is the lead sponsor of 111 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • pain and paresthesia in the median nerve distribution
  • increasing symptoms during the night,
  • positive Tinel sign,
  • positive Phalen sign,
  • symptoms had to have persisted for at least 6 months
  • deficits of sensory and motor median nerve conduction according to guidelines of the American Association of Electrodiagnosis, American Academy of Neurology, and the American Physical Medicine and Rehabilitation Academy

Exclusion criteria

Exclusion Criteria:

  • any sensory/motor deficit related to the ulnar or radial nerve;
  • older than 65 years of age;
  • previous surgical intervention or steroid injections;
  • multiple diagnoses of the upper extremity (eg, cervical radiculopathy);
  • history of neck, shoulder, or upper limb trauma (whiplash);
  • history of a systemic disease causing CTS (eg, diabetes mellitus or thyroid disease);
  • history of other medical conditions (eg, rheumatoid arthritis, fibromyalgia);
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Physical Therapy Group

    The physical therapy group will receive 3 treatment sessions of manual therapy including desensitization maneuvers of the central nervous system of 30 minutes of duration, once per week.

    Other: Physical Therapy Group

  • Active comparator
    Surgical Group

    The surgical group will receive a surgical procedure consisting of the decompression and release of the median nerve at the carpal tunnel performed by an experienced surgeon according to standardized protocols.

    Other: Surgical Group

Interventions

  • OtherSurgical Group

    The surgical group will receive a surgical procedure consisting of the decompression and release of the median nerve at the carpal tunnel performed by an experienced surgeon according to standardized protocols.

  • OtherPhysical Therapy Group

    The physical therapy group will receive 3 treatment sessions of manual therapy including desensitization maneuvers of the central nervous system of 30 minutes of duration, once per week.

06

What researchers measure

Primary outcomes

  1. Changes in widespread pressure pain thresholds between baseline and follow-up periods

    Pressure pain thresholds over the median, ulnar and radial nerves, and over the cervical spine, the second metacarpal, and tibialis anterior muscles will be bilaterally assessed.

    Time frame: Baseline and 3, 6, 9 and 12 months after the intervention.

Secondary outcomes

  1. Changes in heat and cold pain thresholds between baseline and follow-up periods

    Heat and cold pain thresholds over the carpal tunnel and the thenar eminence will be bilaterally assessed.

    Time frame: Baseline and 3, 6, 9 and 12 months after the intervention

  2. Changes in pain intensity between baseline and follow-ups periods

    An 11-point Numerical Pain Rating Scale (NPRS, 0: no pain - 10: maximum pain) will be used to assess the patients' current level of hand pain and the worst and lowest level of pain experienced in the preceding week. The mean value of the 3 scores will be used in the analysis at each follow-up period.

    Time frame: Baseline and 3, 6, 9 and 12 months after the intervention

07

Study locations

2 sites
  • Hospital Universitario Fundación Alcorcon
    Alcorcón, Madrid 28922, Spain
  • Universidad Rey Juan Carlos
    Alcorcón, Madrid 28922, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02219919
Lead sponsor
Universidad Rey Juan Carlos
Collaborators
Hospital Universitario Fundación Alcorcón, Hospital San Carlos, Madrid
Responsible party
César Fernández-de-las-Peñas (Proffesor, Universidad Rey Juan Carlos) — Principal investigator
First posted
Aug 19, 2014
Start date
Aug 2014
Primary completion
May 2016
Completion
May 2016
Last update
May 12, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion